drugset / Trial / NCT01634087
A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a study of itacitinib in patients with chronic plaque psoriasis. This study will evaluate safety and efficacy parameters of itacitinib.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-01
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itacitinib | Small molecule | 100 mg | Oral |
| Subject | Itacitinib | Small molecule | 200 mg | Oral |
| Subject | Itacitinib | Small molecule | 600 mg | Oral |